More articles from IMMUNOPHARMACOLOGY

You have access
Modulation of Mouse Endotoxin Shock by Inhibition of Phosphatidylcholine-Specific Phospholipase C
Klaus Tschaikowsky, J. Schmidt and M. Meisner

Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 800-804;
You have access
IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation
Mauro Brunetti, Antonella Colasante, Nicola Mascetra, Mauro Piantelli, Piero Musiani and Francesca B. Aiello

Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 915-919;
You have access
Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes
Gunther Hartmann, Anne Krug, Martin Bidlingmaier, Ulrich Hacker, Andreas Eigler, Richard Albrecht, Christian J. Strasburger and Stefan Endres

Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 920-928;
You have access
Thapsigargin-Induced Secretion Is Dependent on Activation of a Cholera Toxin-Sensitive and Phosphatidylinositol-3-kinase-Regulated Phospholipase D in a Mast Cell Line
David S. Cissel, Paul F. Fraundorfer and Michael A. Beaven

Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 110-118;
You have access
Diaminic Carbonates, a New Class of Anti-inflammatory Compounds: Their Biological Characterization and Mode of Action
Giuliana Porro, Giorgio Bertolini, M. Antonietta Bonardi, Elena Giovanetti, Paola Lento, Flavio Leoni, Daniela Modena, Gianfranco Pavich and Fabrizio Marcucci

Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 193-200;
You have access
In Vitro Immunosuppressive Activity, Isolation from Pig Liver Microsomes and Identification by Electrospray ms-ms of a New FK-506 C₁₉-C₂₀ Epoxide Metabolite
G. Lhoëst, R. Dieden, R.K. Verbeeck, N. Maton, A. Ingendoh and D. Latinne

Journal of Pharmacology and Experimental Therapeutics March 1998, 284 (3) 1074-1081;
You have access
Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models
Jeffrey R. Jackson, Brian Bolognese, Leonard Hillegass, Shouki Kassis, Jerry Adams, Don E. Griswold and James D. Winkler

Journal of Pharmacology and Experimental Therapeutics February 1998, 284 (2) 687-692;
You have access
Detection of Kappa Opioid Receptors on Mouse Thymocyte Phenotypic Subpopulations as Assessed by Flow Cytometry
Tracey A. Ignatowski and Jean M. Bidlack

Journal of Pharmacology and Experimental Therapeutics January 1998, 284 (1) 298-306;
You have access
SB 207499 (Ariflo), a Potent and Selective Second-Generation Phosphodiesterase 4 Inhibitor: In VitroAnti-inflammatory Actions
Mary S. Barnette, Siegfried B. Christensen, David M. Essayan, Marilyn Grous, Uma Prabhakar, Julia A. Rush, Anne Kagey-Sobotka and Theodore J. Torphy

Journal of Pharmacology and Experimental Therapeutics January 1998, 284 (1) 420-426;
You have access
The Role of Platelet-Activating Factor (PAF) and the Efficacy of ABT-491, a Highly Potent and Selective PAF Antagonist, in Experimental Allergic Rhinitis
Daniel H. Albert, Peter E. Malo, Paul Tapang, Thomas K. Shaughnessy, Douglas W. Morgan, Craig D. Wegner, Michael L. Curtin, George S. Sheppard, Lianhong Xu, Steven K. Davidsen, James B. Summers and George W. Carter

Journal of Pharmacology and Experimental Therapeutics January 1998, 284 (1) 83-88;

Main menu

User menu

Search

More articles from IMMUNOPHARMACOLOGY

Pages

Navigate

More Information

ASPET's Other Journals